Bacteriostatic Water · 10 mLIDR 69.60016 in stock
RESEARCH PEPTIDE
Tirzepatide 10 mg
Tirzepatide 10 mg
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for coordinated incretin signalling and glucose-dependent metabolic pathways.
About this research category
Dual GIP/GLP-1 receptor research. Evidence for a studied medicinal formulation does not establish this research vial as an approved or safe treatment.
Labels describe study topics - not proven benefits, personal-use guidance or product compatibility.
Read the primary study ↗IDR 887.900
4 in stock
Line total: IDR 887.900
Laboratory supplies
Need bacteriostatic water?
Add BAC water to your order if required by your laboratory protocol. Choose the size below; compatibility depends on your research requirements.
Bacteriostatic Water · 10 mLIDR 69.600
Bacteriostatic Water · 3 mLIDR 40.00085 in stock
Optional add-on, not added automatically. BAC water does not count towards the peptide-vial discount threshold.
Explore more research materials
Other listings in this category - not a recommendation to combine products.
AOD-9604 · 10 mgIDR 2.530.000Research categoryWEIGHT MANAGEMENT
BPC-157 · 10 mgIDR 1.140.600Research categoryRECOVERY- Product
- Tirzepatide
- Strength
- 10 mg
- Category
- Research Peptides
- Purity
- ≥99.6% PURITY
- Use
- Laboratory and scientific research only
- Price
- IDR 887.900
- Availability
- 4 in stock
The power of dual-incretin receptor research.
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for coordinated incretin signalling and glucose-dependent metabolic pathways.
Research context
Preclinical characterisation examines coordinated GIP and GLP-1 receptor agonism, downstream cAMP signalling, and glucose-dependent metabolic responses. This mechanism-led profile does not promise weight-loss, glycaemic, appetite, or cardiovascular outcomes.
Research interests
- GIP receptor signalling
- GLP-1 receptor signalling
- Glucose-dependent metabolic pathways
Explore further
Related research products
Browse the same catalogue category. These listings do not indicate compatibility or suitability for use together.
Research Peptides≥99.6% PURITYAOD-9604
Research categoryWEIGHT MANAGEMENT10 mg
AOD-9604 is a modified C-terminal growth-hormone fragment studied in preclinical lipid-metabolism, fat-oxidation, and adipose-signalling models.
≥99.6% PURITY
IDR 2.530.000
2 in stockResearch Peptides≥99.6% PURITYBPC-157
Research categoryRECOVERY10 mg
BPC-157 is studied in preclinical models of tendon-fibroblast migration, FAK–paxillin activation, and tissue-repair signalling.
≥99.6% PURITY
IDR 1.140.600
11 in stock
Research Peptides≥99.6% PURITYCJC-1295
Research categoryGROWTH HORMONE5 mg
CJC-1295 is studied within growth hormone-releasing hormone research for its influence on GH and IGF-1 signalling.
≥99.6% PURITY
IDR 934.800
14 in stock
Research Peptides≥99.6% PURITYDSIP
Research categorySLEEP10 mg
DSIP is an exploratory neuropeptide studied at the intersection of slow-wave EEG activity, sleep signalling, and neuroendocrine regulation.
≥99.6% PURITY
IDR 954.000
1 in stock